59 Optical Coherence Tomography Papers Presentations at Transcatheter Cardiovascular Therapeutics Conference (TCT 2009)

Optical Coherence Tomography (OCT) continues to make substantial progress in cardiovascular applications as evidence by the impressive number of OCT papers presented at this years Transcatheter Cardiovascular Therapeutics Conference (TCT 2009). The table below contains a list of the presenters and titles. Additional information on these talks can be found in the Symposia CD when it is released. See the Cardiology category above for additional information on OCT in cardiology.
Number |
Presenter |
Title |
Presentation Type |
1 |
Brett Bouma |
OCT 1: Generational Advances, Pattern Recognition, and Limitations |
Session Talk |
2 |
Marc Feldman |
OCT 2: Can OCT Image Cells in Vivo? |
Session Talk |
3 |
Brett Bouma |
OCT 3: OCT Imaging, Vulnerable Plaque, and a Natural History Study |
Session Talk |
4 |
Giulio Guagliumi |
OCT 4: Lesson from Stenting Stable and Unstable Plaques |
Session Talk |
5 |
Takashi Akasaka |
OCT 5: Comparative Imaging Results with OCT IVUS and Angioscopy |
Session Talk |
6 |
Carlo DiMario |
Preliminary OCT Observations of Interest (and perhaps importance) in Bifurcation Disease (case examples) |
Session Talk |
7 |
Nieves Gonzalo |
Acute effects of stent implantation on the vessel wall: An OCT study |
Poster Abstract |
8 |
Michael Aboodi |
Temporal changes in strut coverage by OCT in BMS versus DES: Clinical implications for the evaluation and quantification of vascular healing in vivo |
Poster Abstract |
9 |
Nieves Gonzalo |
Reproducibility of quantitative OCT for stent analysis |
Poster Abstract |
10 |
Masato Mizukoshi |
Neointimal coverage on the stent struts across ostia of arterial branches differs in the vessel size of the sidebranch: |
Poster Abstract |
11 |
Nieves Gonzalo |
New generation OCT in clinical practice |
Poster Abstract |
12 |
Konstantina Bouki |
Elevated serum high- sensitivity C-reactive protein predicts plaque rupture and thin-cap fibroatheroma: Detected by OCT |
Poster Abstract |
13 |
Michael Aboodi |
Clinical significance of the “protruding strut” evaluated by OCT: Implications for neointimal formation and strut coverage following DES implantation |
Poster Abstract |
14 |
Nieves Gonzalo |
In vivo assessment of high-risk coronary plaques at bifurcations with combined OCT and IVUS virtual histology |
Poster Abstract |
15 |
Armando Tellez |
Long-term patterns of neointimal formation following bare metal stents in the LDL Receptor deficient swine: An OCT histology correlation study |
Poster Abstract |
16 |
Toshiro Shinke |
OCT analysis of target vessel failure after drug eluting and bare metal coronary stent |
Poster Abstract |
17 |
Nieves Gonzalo |
OCT patterns in stent restenosis |
Poster Abstract |
18 |
Nieves Gonzalo |
Relation Between plaque type and dissections at the edges after stent implantation: An OCT Study |
Oral Abstract |
19 |
Sang Min Park |
Comparison of Neointimal coverage of drug-eluting stents between diabetic and non-diabetic patients using OCT at nine months after implantation |
Oral Abstract |
20 |
Nieves Gonzalo |
Incomplete Stent Apposition and Delayed Tissue Coverage are more frequent in DES implanted during primary PCI for ST-Elevation Myocardial Infarction than in drug-eluting stents implanted for Stable and Unstable angina: Insights from OCT |
Oral Abstract |
21 |
Antreas Synetos |
Culprit lesions located in the proximal segments of the coronary arteries have thinner fibrous cap and greater incidence of plaque rupture: an OCT study |
Oral Abstract |
22 |
Giulio Guagliumi |
The Boston Scientific JACTAX Paclitaxel-eluting stent programs: Focus on the randomized OCTDESI strut coverage evaluation |
Session Talk |
23 |
Gary Mintz |
IVUS, OCT or Spectroscopic Imaging combined with therapeutic devices |
Session Talk |
24 |
Nagal Hiroyuki |
DES Restenosis evaluated by OCT and Histology |
Session Talk |
25 |
Sergio Tarbine |
OCT Guided treatment of In-stent restenosis |
Session Talk |
26 |
Toshiyo Satoh |
Very Late Thrombosis Evaluated with OCT |
Session Talk |
27 |
Jose Costa |
Ten-Year invasive (Angio/IVUS/OCT) follow-up of the first SES Implanted in Humans |
Session Talk |
28 |
Juan Granada |
Meaningful mechanistic insights on nitinol stent behavior from advanced imaging modalities (IVUS and OCT) |
Session Talk |
29 |
Francesco Prati |
COCKTAIL: A prospective randomized trial of intracoronary abciximab infusion patients with thrombotic lesions assessed by OCT |
Session Talk |
30 |
Giulio Guagliumi |
OCTAMI: A prospective randomized trial of zotarolimus-eluting and bare-metal stents in STEMI assessed by OCT |
Session Talk |
31 |
Giulio Guagliumi |
We will only use OCT! |
Live case Discussion |
32 |
Brett Bouma |
OCT Image generation and Devices: first, second and next generation OCT technology |
Session Talk |
33 |
Takashi Kubo |
Currently applied plaque recognition criteria and beyond (macrophage, thrombus, and unstable lesion morphology) |
Session Talk |
34 |
Francesco Prati |
Stent apposition, tissue coverage, and related findings (prolapse, edge dissections, etc.) |
Session Talk |
35 |
Marco Costa |
Artifacts in OCT images |
Session Talk |
36 |
Akiko Maehara |
OCT Findings: Comparison with other Imaging modalities |
Session Talk |
37 |
Guillermo Tearney |
Intracoronary OCT standardization and validation |
Session Talk |
38 |
Bouma, Costa, Kubo, Maehara, Prati, Tearney |
Discussion and Q and A: What will be necessary to transform OCT into a clinically useful tool? |
Session Talk |
39 |
Junya Shite |
OCT in acute coronary syndromes |
Session Talk |
40 |
Sergio Waxman |
OCT in vulnerable plaque |
Session Talk |
41 |
Takashi Kubo |
OCT Findings during PCI and stent implantation |
Session Talk |
42 |
Giulio Guagliumi |
DES Follow-up and Clinical/ Surrogate endpoints |
Session Talk |
43 |
Kubo, Shite, Waxman |
Discussion: The clinical utility of OCT today and tomorrow |
Session Talk |
44 |
Sudhir Rathore |
OCT Case 1 |
Case Presentation |
45 |
Giora Weisz |
OCT Case 2 |
Case Presentation |
46 |
Vasile Sirbu |
OCT Case 3 |
Case Presentation |
47 |
Fransesco Prati |
OCT Case 4 |
Case Presentation |
48 |
Refat Jabara |
OCT Imaging in Drug development phase III decisions, surrogate endpoints, and phase IV safety |
Session Talk |
49 |
Juan Granada |
OCT in the evaluation of vascular healing following stent implantation |
Session Talk |
50 |
Evelyn Regar |
OCT Imaging in Bioabsorbable Scaffoldings |
Session Talk |
51 |
Granada, Jabara, Regar |
Discussion: What more do we need before OCT should be used to guide Drug and device development? |
Session Talk |
52 |
Yudai Chen |
Novel DES insights from OCT |
Evening Asia Pacific Symposium |
53 |
Takashi Akasaka |
OCT Imaging Case Presentation |
Evening Asia Pacific Symposium |
54 |
Akasaka, Chen, Hong, Lo |
Discussion: Will OCT replace IVUS fro procedural guidance and follow-up? |
Evening Asia Pacific Symposium |
55 |
Patrick Serruys G, Guagliumi |
Introduction: Frequency Domain OCT: Fast, Simple, and Easy to Read: The Emerging Gold Standard for Stent Management |
LightLab Breakfast Symposium |
56 |
Carlo DiMario |
OCT Case Review 1 |
LightLab Breakfast Symposium |
57 |
Fransesco Prati |
OCT Case Review 2 |
LightLab Breakfast Symposium |
58 |
Evelyn Regar |
OCT Case Review 3 |
LightLab Breakfast Symposium |
59 |
Giulio Guagliumi |
OCT Closing Remarks |
LightLab Breakfast Symposium |
Login to comment.